I particularly like this part of the trading update...
All key partnerships have also either been renegotiated or are being
renegotiated and the Company is in late stage discussions with a number of top
10 pharmaceutical companies for new commercialisation initiatives across its
range of technologies. Feasibility programmes are taking place across the
ingestible and non-ingestible product range with new partners, emphasising
BioProgress' rapid commercialisation solutions. In addition, the Company has
entered into evaluation contracts with a number of large pharmaceutical
companies.